$29.40
0.53[1.84%]
At close: Apr 19
$29.40
0[0.00%]
After Hours: 4:00PM EDT
Supernus Pharmaceuticals
(NASDAQ:SUPN)Overview Rating
Speculative
Supernus Pharmaceuticals Stock (NASDAQ:SUPN), Quotes and News Summary
Supernus Pharmaceuticals Stock (NASDAQ: SUPN) stock price, news, charts, stock research, profile.
| Open | $28.670 |
| Close | $29.400 |
| Volume / Avg. | 361.633K / 401.621K |
| Day Range | 28.670 - 29.530 |
| 52 Wk Range | 21.990 - 39.090 |
| Market Cap | $1.609B |
| P/E Ratio | 1.444K |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 38 |
| Short Interest | 13.27% |
| Days to Cover | 9.95 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Supernus Pharmaceuticals Inc
Sector
Health Care
Industry
Pharmaceuticals
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in develo...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Supernus Pharmaceuticals (SUPN) stock?
You can purchase shares of Supernus Pharmaceuticals (NASDAQ: SUPN) through any online brokerage.
Who are Supernus Pharmaceuticals's (SUPN) competitors?
Other companies in Supernus Pharmaceuticals’s space includes: Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP), Neumora Therapeutics (NASDAQ:NMRA) and Axsome Therapeutics (NASDAQ:AXSM).
What is the target price for Supernus Pharmaceuticals (SUPN) stock?
The latest price target for Supernus Pharmaceuticals (NASDAQ: SUPN) was reported by Piper Sandler on Wednesday, February 28, 2024. The analyst firm set a price target for 41.00 expecting SUPN to rise to within 12 months (a possible 39.46% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Supernus Pharmaceuticals (SUPN)?
The stock price for Supernus Pharmaceuticals (NASDAQ: SUPN) is $29.4 last updated April 19, 2024 at 4:00 PM EDT.
Does Supernus Pharmaceuticals (SUPN) pay a dividend?
There are no upcoming dividends for Supernus Pharmaceuticals.
When is Supernus Pharmaceuticals (NASDAQ:SUPN) reporting earnings?
Supernus Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
Is Supernus Pharmaceuticals (SUPN) going to split?
There is no upcoming split for Supernus Pharmaceuticals.
What sector and industry does Supernus Pharmaceuticals (SUPN) operate in?
Supernus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.